Literature DB >> 8990098

Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in B-lymphocyte function.

P Rieckmann1, J M Tuscano, J H Kehrl.   

Abstract

Two cytokines important in the regulation of B-cell function are tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). They act at different steps in B-cell differentiation and can be produced by the B cells themselves upon appropriate stimulation. Crosslinking of surface Ig and signaling through CD22 or CD40 lead to increased secretion of both cytokines. Neutralization of TNF-alpha or IL-6 biologic activity in B-cell cultures results in a significant reduction in B-cell proliferation and Ig secretion. Increased production of these cytokines is found in several diseases associated with aberrant B-cell function. This review will focus on the role of TNF-alpha and IL-6 in normal and pathophysiological conditions of B-cell function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990098     DOI: 10.1006/meth.1996.0396

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  17 in total

1.  The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant?

Authors:  Sesquile Ramon; Steven F Baker; Julie M Sahler; Nina Kim; Eric A Feldsott; Charles N Serhan; Luis Martínez-Sobrido; David J Topham; Richard P Phipps
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  Evaluation of the antirheumatic effects of isoflavone-free soy protein isolate and etanercept in rats with adjuvant-induced arthritis.

Authors:  Nahla E El-Ashmawy; Eman G Khedr; Maha M Shamloula; Maha M Kamel
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-21

3.  Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma.

Authors:  Melissa E Munroe; Thomas R Businga; Joel N Kline; Gail A Bishop
Journal:  J Immunol       Date:  2010-10-01       Impact factor: 5.422

4.  Family-based analyses reveal novel genetic overlap between cytokine interleukin-8 and risk for suicide attempt.

Authors:  E E M Knowles; Joanne E Curran; Harald H H Göring; Samuel R Mathias; Josephine Mollon; Amanda Rodrigue; Rene L Olvera; Ana Leandro; Ravi Duggirala; Laura Almasy; John Blangero; David C Glahn
Journal:  Brain Behav Immun       Date:  2019-04-03       Impact factor: 7.217

Review 5.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Chary López-Pedrera; Maria Ángeles Aguirre; Nuria Barbarroja; Maria José Cuadrado
Journal:  J Biomed Biotechnol       Date:  2010-09-26

6.  Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo.

Authors:  Genevieve M Weir; Mohan Karkada; David Hoskin; Marianne M Stanford; Lisa MacDonald; Marc Mansour; Robert S Liwski
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

7.  TGF-beta-induced interleukin-6 participates in transdifferentiation of human Tenon's fibroblasts to myofibroblasts.

Authors:  Gong Je Seong; Samin Hong; Sun-Ah Jung; Jung-Jin Lee; Eunhae Lim; Sung-Joo Kim; Joon H Lee
Journal:  Mol Vis       Date:  2009-10-21       Impact factor: 2.367

8.  SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus.

Authors:  Martin Aringer; Josef S Smolen
Journal:  Arthritis Res Ther       Date:  2003-05-14       Impact factor: 5.156

9.  Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles.

Authors:  Maria Malm; Kirsi Tamminen; Suvi Lappalainen; Timo Vesikari; Vesna Blazevic
Journal:  J Immunol Res       Date:  2016-09-04       Impact factor: 4.818

Review 10.  Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis.

Authors:  Svitlana Garbuzova-Davis; Jared Ehrhart; Paul R Sanberg; Cesario V Borlongan
Journal:  Int J Mol Sci       Date:  2018-01-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.